OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy
Liang Zhao, Dongdong Li, Yuxi Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13821-13833
Closed Access | Times Cited: 33
Liang Zhao, Dongdong Li, Yuxi Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13821-13833
Closed Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
Shuangneng Yin, Zhaojun Chen, Dugang Chen, et al.
Theranostics (2023) Vol. 13, Iss. 5, pp. 1520-1544
Open Access | Times Cited: 64
Shuangneng Yin, Zhaojun Chen, Dugang Chen, et al.
Theranostics (2023) Vol. 13, Iss. 5, pp. 1520-1544
Open Access | Times Cited: 64
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy
Yue Wang, Shikun Zhou, Yan Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Yue Wang, Shikun Zhou, Yan Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 10
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 10
Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy
Junjie Liu, Gaoming Li, Honghua Guo, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 10, pp. 12809-12821
Closed Access | Times Cited: 19
Junjie Liu, Gaoming Li, Honghua Guo, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 10, pp. 12809-12821
Closed Access | Times Cited: 19
Development of delivery strategies for CRISPR‐Cas9 genome editing
Qi Liu, Jianhui Yang, Yumeng Xing, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 19
Qi Liu, Jianhui Yang, Yumeng Xing, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 19
AIPH‐Encapsulated Thermo‐Sensitive Liposomes for Synergistic Microwave Ablation and Oxygen‐Independent Dynamic Therapy
Wenjie Zhang, Hu Zhou, Deyan Gong, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Closed Access | Times Cited: 18
Wenjie Zhang, Hu Zhou, Deyan Gong, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Closed Access | Times Cited: 18
Remodeling Tumor Immunogenicity with Dual-Activatable Binary CRISPR Nanomedicine for Cancer Immunotherapy
Yumeng Xing, Jianhui Yang, Yunlong Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 6, pp. 5713-5726
Closed Access | Times Cited: 17
Yumeng Xing, Jianhui Yang, Yunlong Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 6, pp. 5713-5726
Closed Access | Times Cited: 17
Optimization of lipid assisted polymeric nanoparticles for siRNA delivery and cancer immunotherapy
Song Lin, Houjin Jing, Xiao‐Jiao Du, et al.
Biomaterials Science (2024) Vol. 12, Iss. 8, pp. 2057-2066
Closed Access | Times Cited: 8
Song Lin, Houjin Jing, Xiao‐Jiao Du, et al.
Biomaterials Science (2024) Vol. 12, Iss. 8, pp. 2057-2066
Closed Access | Times Cited: 8
Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy
Bingchen Zhang, Chunmei Lai, Bang-Yue Luo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3205-3217
Open Access | Times Cited: 8
Bingchen Zhang, Chunmei Lai, Bang-Yue Luo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3205-3217
Open Access | Times Cited: 8
Harnessing the evolving CRISPR/Cas9 for precision oncology
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Tianye Li, Shuiquan Li, Yue Kang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Hierarchical-unlocking virus-esque NanoCRISPR precisely disrupts autocrine and paracrine pathway of VEGF for tumor inhibition and antiangiogenesis
Shuang Ma, Yingjie Li, Furong Liu, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 505-518
Closed Access | Times Cited: 7
Shuang Ma, Yingjie Li, Furong Liu, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 505-518
Closed Access | Times Cited: 7
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer
Gayathri Kandasamy, Yugeshwaran Karuppasamy, Uma Maheswari Krishnan
Vaccines (2023) Vol. 11, Iss. 2, pp. 458-458
Open Access | Times Cited: 16
Gayathri Kandasamy, Yugeshwaran Karuppasamy, Uma Maheswari Krishnan
Vaccines (2023) Vol. 11, Iss. 2, pp. 458-458
Open Access | Times Cited: 16
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting
Ashok Kumar Jangid, Kyobum Kim
Advances in Colloid and Interface Science (2024) Vol. 333, pp. 103301-103301
Closed Access | Times Cited: 5
Ashok Kumar Jangid, Kyobum Kim
Advances in Colloid and Interface Science (2024) Vol. 333, pp. 103301-103301
Closed Access | Times Cited: 5
Degradable CRISPR/Cas9 nanosystem activated by NIR-II light targets genome editing of PD-L1 and metabolic modulation for enhanced antitumor immunity
Xiaoyi Zhao, Kangli Guo, Kai Zhang, et al.
Nano Today (2024) Vol. 55, pp. 102186-102186
Closed Access | Times Cited: 4
Xiaoyi Zhao, Kangli Guo, Kai Zhang, et al.
Nano Today (2024) Vol. 55, pp. 102186-102186
Closed Access | Times Cited: 4
Smart Delivery Vehicles for Cancer: Categories, Unique Roles and Therapeutic Strategies
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4
Nanotechnology-enhanced CRISPR systems for gene therapy – A review
M.A. Kareem, Ashwini Aher, Sunil Thitame
Multidisciplinary Reviews (2025) Vol. 8, Iss. 7, pp. 2025225-2025225
Closed Access
M.A. Kareem, Ashwini Aher, Sunil Thitame
Multidisciplinary Reviews (2025) Vol. 8, Iss. 7, pp. 2025225-2025225
Closed Access
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Immunogenic Cell Death and Metabolic Reprogramming in Cancer: Mechanisms, Synergies, and Innovative Therapeutic Strategies
Jie Jiang, Ying Yan, Chunhui Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 950-950
Open Access
Jie Jiang, Ying Yan, Chunhui Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 950-950
Open Access
The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation
Amrita Arup Roy, Abhijeet Pandey, Namdev Dhas, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2025) Vol. 2025, Iss. 1
Open Access
Amrita Arup Roy, Abhijeet Pandey, Namdev Dhas, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2025) Vol. 2025, Iss. 1
Open Access
Hemoglobin-loaded hollow mesoporous carbon-gold nanocomposites enhance microwave ablation through hypoxia relief
Yitian Zhang, Bingge Li, Jiawen He, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Yitian Zhang, Bingge Li, Jiawen He, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
NIR-II Light-driven genetically edited nanoparticles with inherent CRT-inducing capability for macrophage-mediated immunotherapy
Qiaoyi Huang, Miao Su, Liang Zhao, et al.
Nano Today (2023) Vol. 50, pp. 101857-101857
Closed Access | Times Cited: 10
Qiaoyi Huang, Miao Su, Liang Zhao, et al.
Nano Today (2023) Vol. 50, pp. 101857-101857
Closed Access | Times Cited: 10
Remodeling of Effector and Regulatory T Cells by Capture and Utilization of miRNAs Using Nanocomposite Hydrogel for Tumor-Specific Photothermal Immunotherapy
Li Chen, Man Zhu, Handan Zhang, et al.
ACS Nano (2025)
Closed Access
Li Chen, Man Zhu, Handan Zhang, et al.
ACS Nano (2025)
Closed Access
